A phase I pharmacokinetic study to evaluate single and multiple doses of Cannabidiol in healthy subjects, both in the fasting and fed states
Latest Information Update: 20 Nov 2020
At a glance
- Drugs Cannabidiol (Primary)
- Indications Cardiovascular disorders; Diastolic heart failure; Myocarditis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Cardiol Therapeutics
- 20 Nov 2020 New trial record